Neogen Chemicals' revenue increased 42.4% YoY
  • 03 Nov 2026
  • Neogen Chemicals Ltd reported a 18.0% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2026-27). On a year-on-year (YoY) basis, it witnessed a growth of 42.4%.
  • Its expenses for the quarter were up by 24.3% QoQ and 39.8% YoY.
  • The net profit decreased 51.9% QoQ and increased 144.2% YoY.
  • The earnings per share (EPS) of Neogen Chemicals Ltd stood at 2.96 during Q2 FY 2026-27.

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Neogen Chemicals Ltd is a reputed player in the specialty chemicals industry, primarily engaged in the manufacturing of bromine and lithium-based compounds. These chemicals are used in a variety of applications, including pharmaceuticals, agrochemicals, and other industrial sectors. The company has established itself as a leader in its niche, leveraging its expertise in complex chemical processes to cater to both domestic and international markets. Recent developments in the company may include expansion plans or strategic partnerships, though specific recent developments are not detailed in the provided dataset.

In the second quarter of the fiscal year 2027 (Q2FY27), Neogen Chemicals Ltd reported a total income of ₹299.92 crores, reflecting an increase of 18.0% from the previous quarter (Q1FY27), where the total income stood at ₹254.15 crores. Compared to the same quarter in the previous fiscal year (Q2FY26), there was a significant year-over-year growth of 42.4%, with total income in Q2FY26 at ₹210.55 crores. This substantial increase in revenue on both a quarterly and annual basis is indicative of the company's growth trajectory in terms of sales and customer reach.

Neogen Chemicals Ltd experienced a decline in profitability when comparing Q2FY27 to Q1FY27. The company reported a profit before tax (PBT) of ₹12.71 crores in Q2FY27, a decrease of 44.9% from the previous quarter's ₹23.08 crores. Nonetheless, when compared year-over-year, there is a noticeable improvement of 151.2% from Q2FY26, where the PBT was ₹5.06 crores. The profit after tax (PAT) followed a similar trend, registering at ₹8.23 crores in Q2FY27, which is a decrease of 51.9% from the previous quarter's ₹17.11 crores, but a substantial increase of 144.2% from ₹3.37 crores in Q2FY26.

The total expenses for Neogen Chemicals Ltd in Q2FY27 were ₹287.21 crores, marking a 24.3% increase from Q1FY27's expenses of ₹231.07 crores. Year-over-year, expenses increased by 39.8% from ₹205.49 crores in Q2FY26. The earnings per share (EPS) for Q2FY27 was ₹2.96, down 52.9% from ₹6.29 in Q1FY27, but up by 131.3% from ₹1.28 in Q2FY26. These metrics indicate fluctuations in operating efficiency and cost management across different periods. The tax burden was ₹4.49 crores in Q2FY27, which is a decrease of 27.2% from Q1FY27's ₹6.17 crores, but an increase of 152.2% from ₹1.78 crores in Q2FY26.

Neogen Chemicals Ltd announced its Q2 FY 2026-27 results on 3 November, 2026.

Neogen Chemicals Ltd quarterly results refer to the company’s financial performance over a three-month period, including key metrics like revenue, net profit, earnings per share (EPS), and margin performance.

Key highlights of Neogen Chemicals Ltd Q2 FY 2026-27 results include:

  • Revenue: ₹299.92 crore
  • Net Profit: ₹8.23 crore
  • EBITDA: ₹49.28 crore
  • Year-over-Year Growth: 42.4%
  • Quarter-over-Quarter Growth: 18.0%

Neogen Chemicals Ltd reported a net loss of ₹8.23 crore in Q2 FY 2026-27, reflecting a 144.2% year-over-year growth.

Neogen Chemicals Ltd posted a revenue of ₹299.92 crore in Q2 FY 2026-27.